XORTX Therapeutics Inc (XRTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.40
• Market Cap: $2.72M
• EPS: $-0.40
• 52-Week High: $1.41
• 52-Week Low: $0.37

Market Sentiment

XORTX Therapeutics Inc currently has a Bullish sentiment score of 0.30.

About XORTX Therapeutics Inc

XORTX Therapeutics Inc. is a Vancouver-based biopharmaceutical company dedicated to developing innovative therapies for progressive kidney diseases and related metabolic disorders, including hypertension and diabetic nephropathy. The company is advancing its proprietary drug candidates through clinical development with a focus on addressing significant unmet medical needs and improving patient outcomes. By leveraging cutting-edge research and forming strategic partnerships, XORTX aims to succ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for XORTX Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XRTX pay dividends?

XORTX Therapeutics Inc (XRTX) does not currently pay a regular dividend.

What is XRTX's market cap?

XORTX Therapeutics Inc (XRTX) has a market capitalization of $2.72M with a current stock price of $0.40.